on MeVis Medical Solutions AG (ETR:M3V)
MeVis Medical Solutions AG Revises Fiscal Forecast
Bremen, September 28, 2026 – MeVis Medical Solutions AG has announced a downward revision of its financial forecast for the 2025/2026 fiscal year. The leading software company specializing in image-based medicine cited subdued demand in the mammography sector for its customer Hologic and a slow rollout of lung cancer screening in Germany as primary factors impacting revenue.
Preliminary figures suggest expected revenue will decrease to between €15.0 million and €15.5 million, down from the previously forecasted €16.5 million to €17.0 million. Consequently, the company anticipates negative earnings before interest and taxes (EBIT), projected to be between € -1.0 million and € -1.5 million, assuming a stable exchange rate of 1.16 USD/EUR.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MeVis Medical Solutions AG news